CVS Health vs Regeneron Pharmaceuticals
CVS Health (CVS), health care, and Regeneron Pharmaceuticals (REGN), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
CVS Health is worth $111B on the stock market and Regeneron Pharmaceuticals $99.2B: CVS Health is valued at 12% more. CVS Health trades at 10.1 times earnings and Regeneron Pharmaceuticals at 21.2; operating margins in their latest fiscal years were 1.16% and 24.9%. Over the past year CVS Health's share price has moved +13.7% and Regeneron Pharmaceuticals's +31.3%.
Key facts
- CVS Health market value
- $111B
- Regeneron Pharmaceuticals market value
- $99.2B
- CVS Health P/E
- 10.1
- Regeneron Pharmaceuticals P/E
- 21.2
- CVS Health revenue
- $402.1BFY to 2025-12-31
- Regeneron Pharmaceuticals revenue
- $14.3BFY to 2025-12-31
- Superinvestors holding both
- 5
Market values as of .
| Measure | CVS Health | Regeneron Pharmaceuticals |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $111Bhigher | $99.2Blower |
| Revenue | $402.1Bhigher | $14.3Blower |
| Earnings | $1.8Blower | $4.5Bhigher |
| Employees | 219,000higher | 15,410lower |
| Total assets | $253.5Bhigher | $40.6Blower |
| Valuation | ||
| P/E | 10.1lower | 21.2higher |
| P/S | 0.3lower | 6.9higher |
| P/B | 1.4lower | 2.9higher |
| Dividend yield | 3.00%higher | 0.39%lower |
| Profitability | ||
| Operating margin | 1.16%lower | 24.9%higher |
| Balance sheet | ||
| Net assets | $75.2Bhigher | $31.3Blower |
| Total liabilities | $178.2Bhigher | $9.3Blower |
| Total debt | $64.6Bhigher | $2Blower |
| Cash on hand | $8.5Bhigher | $3.1Blower |
| Price change | ||
| Today | -2.09%lower | +0.66%higher |
| 1 year | +13.7%lower | +31.3%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (5)
- Dodge & Cox team2.1% / 1.9%
- Josef Lakonishok0.7% / 0.3%
- Jim Simons (1938–2024)0.3% / 0.3%
- Ray Dalio (founder)0.2% / 0.1%
- Jeremy Grantham (co-founder)0.1% / 0.1%
CVS Health only (17)
- Larry Robbins10.0%
- Prem Watsa8.8%
- Christopher Davis4.4%
- Samantha McLemore2.8%
- Richard Pzena2.6%
- Andreas Halvorsen1.1%
- Charles Brandes (founder)0.9%
- Mark Boyar0.8%
- John Rogers0.7%
- Brandon Haley0.7%
- Rajiv Jain0.5%
- Steve Cohen0.3%
- Ken Griffin0.3%
- Paul Tudor Jones0.2%
- Israel Englander0.2%
- Primecap team0.1%
- Bill Nygren<0.1%
Regeneron Pharmaceuticals only (5)
Percentages are each holding's share of that investor's reported portfolio (under "Both": CVS Health / Regeneron Pharmaceuticals). Who owns CVS · Who owns REGN
More on CVS Health
Further comparisons
CVS Health against its closest peers
Regeneron Pharmaceuticals against its closest peers
Learn
Questions and answers
Which is bigger, CVS Health or Regeneron Pharmaceuticals?
By market value, CVS Health is the larger: $111B against $99.2B for Regeneron Pharmaceuticals. By revenue in its latest fiscal year, CVS Health is the larger: $402.1B against $14.3B for Regeneron Pharmaceuticals.
Which has the higher P/E ratio?
Regeneron Pharmaceuticals: 21.2, against 10.1 for CVS Health. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Regeneron Pharmaceuticals: 24.9%, against 1.16% for CVS Health. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
CVS Health: 3.00%, against 0.39% for Regeneron Pharmaceuticals. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
CVS Health: $64.6B, against $2B for Regeneron Pharmaceuticals. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both CVS Health and Regeneron Pharmaceuticals?
In their latest 13F filings, Dodge & Cox team, Josef Lakonishok, Jim Simons (1938–2024), Ray Dalio (founder) and Jeremy Grantham (co-founder) hold both.
Cite this page
Funkfolio, “CVS Health vs Regeneron Pharmaceuticals”, data as of 17 November 2026. https://funkfolio.com/compare/cvs-vs-regn
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.